Literature DB >> 15568159

[Topical application of morphine gel in inflammatory mucosal and cutaneous lesions].

M Platzer1, R Likar, C Stein, E Beubler, R Sittl.   

Abstract

AIM: The aim of this study was to demonstrate a peripheral local opioid effect using case examples involving inflammatory mucosal and cutaneous lesions.
METHODS: A 0.1% morphine gel, mixed in the hospital pharmacy, was applied several times daily to inflammatory mucosal lesions (oral, anogenital and in one patient to a skin ulcer). The effects and side effects were documented. RESULT: All patients experienced a significant reduction in pain with the use of topical morphine gel and no side effects were seen.
CONCLUSION: Topical peripheral application of morphine gel is a simple, effective method that can be carried out by patients several times a day with few side effects.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15568159     DOI: 10.1007/s00482-004-0372-9

Source DB:  PubMed          Journal:  Schmerz        ISSN: 0932-433X            Impact factor:   1.107


  15 in total

1.  Treatment of painful skin ulcers with topical opioids.

Authors:  R K Twillman; T D Long; T A Cathers; D W Mueller
Journal:  J Pain Symptom Manage       Date:  1999-04       Impact factor: 3.612

Review 2.  Attacking pain at its source: new perspectives on opioids.

Authors:  Christoph Stein; Michael Schäfer; Halina Machelska
Journal:  Nat Med       Date:  2003-08       Impact factor: 53.440

Review 3.  No pain, no gain: clinical excellence and scientific rigour--lessons learned from IA morphine.

Authors:  Eija Kalso; Lesley Smith; Henry J McQuay; Andrew R Moore
Journal:  Pain       Date:  2002-08       Impact factor: 6.961

4.  Effect of topical morphine for mucositis-associated pain following concomitant chemoradiotherapy for head and neck carcinoma.

Authors:  Leandro C A Cerchietti; Alfredo H Navigante; Marcelo R Bonomi; Mariel A Zaderajko; Pablo R Menéndez; Catalina E Pogany; Berta M C Roth
Journal:  Cancer       Date:  2002-11-15       Impact factor: 6.860

5.  Efficacy of peripheral morphine analgesia in inflamed, non-inflamed and perineural tissue of dental surgery patients.

Authors:  R Likar; W Koppert; H Blatnig; F Chiari; R Sittl; C Stein; M Schäfer
Journal:  J Pain Symptom Manage       Date:  2001-04       Impact factor: 3.612

Review 6.  The control of pain in peripheral tissue by opioids.

Authors:  C Stein
Journal:  N Engl J Med       Date:  1995-06-22       Impact factor: 91.245

7.  Modification of G protein-coupled functions by low-pH pretreatment of membranes from NG108-15 cells: increase in opioid agonist efficacy by decreased inactivation of G proteins.

Authors:  D E Selley; C S Breivogel; S R Childers
Journal:  Mol Pharmacol       Date:  1993-10       Impact factor: 4.436

8.  Painful inflammation-induced increase in mu-opioid receptor binding and G-protein coupling in primary afferent neurons.

Authors:  C Zollner; M A Shaqura; C P Bopaiah; S Mousa; C Stein; M Schafer
Journal:  Mol Pharmacol       Date:  2003-08       Impact factor: 4.436

9.  Pilot study to determine the effectiveness of diamorphine gel to control pressure ulcer pain.

Authors:  Petra Flock
Journal:  J Pain Symptom Manage       Date:  2003-06       Impact factor: 3.612

10.  Effect of morphine sulphate eye drops on hyperalgesia in the rat cornea.

Authors:  N H Wenk; N M Nannenga; N C Honda
Journal:  Pain       Date:  2003-10       Impact factor: 6.961

View more
  4 in total

Review 1.  [Potential applications and significance of peripheral opioid analgesia].

Authors:  J Oeltjenbruns; M Schäfer
Journal:  Schmerz       Date:  2005-10       Impact factor: 1.107

Review 2.  [Topical pain therapy in oral mucositis: a systematic review].

Authors:  H Bornemann-Cimenti; S K Kobald; I S Szilagyi; A Sandner-Kiesling
Journal:  Schmerz       Date:  2013-06       Impact factor: 1.107

3.  [Topical application of morphine and buprenorphine gel has no effect in the sunburn model].

Authors:  J Draxler; M Schuch; A Paul; T Sycha; C Valenta; R Likar; B Gustorff
Journal:  Schmerz       Date:  2008-10       Impact factor: 1.107

4.  Morphine stimulates cell migration of oral epithelial cells by delta-opioid receptor activation.

Authors:  Nada Charbaji; Monika Schäfer-Korting; Sarah Küchler
Journal:  PLoS One       Date:  2012-08-10       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.